Click here to visit TGaS.com
Next milestone in Trinity’s build, buy and partner growth strategy further accelerates the firm’s mission and vision to lead transformation in the life sciences industry
Waltham, MA—Global life sciences consulting firm Trinity today announced it has acquired TGaS® Advisors, the leading benchmarking and advisory services firm for commercial organizations in the life sciences industry. The acquisition marks another proof point in Trinity’s overarching growth strategy and builds upon previous successes and momentum including a strengthened…
Read Now
Boston, August 20, 2018 – Leading global life sciences consulting firm Trinity today announced that it has welcomed new Principal, Christian Frois, PhD, to the firm as well as seven other individuals to its leadership team. Trinity also welcomes new full-time hires, totaling 40 new employees company-wide this year to date.
Frois specializes in the development and evaluation of innovative commercial and evidence strategies for biopharmaceutical and medical device companies, and is a recognized expert on pricing, contracting and market…
Read Now
Trinity’s Breanna Liponis and Alyssa Blaize recently attended Battle Summit to hear firsthand from Memorial Sloan Kettering doctors and researchers how Cycle for Survival funding is helping rare cancer patients everywhere. The team heard about important studies, initiatives and clinical trials funded through Cycle for Survival donors and participants for salivary gland cancer, pancreatic neuroendocrine tumors and advanced melanoma, among other areas. In addition, the team heard the latest updates on Loxo Oncology’s TRK fusion inhibitor, larotrectinib, developed with Cycle…
Read Now
Leading global life sciences consulting firm Trinity today announced that it has been named to the Forbes America’s Best Management Consulting Firms 2018 list. Trinity has been named among the best management consulting firms every year since the inaugural ranking in 2016.
The list, developed by Forbes in partnership with Statista, considers more than 1,300 consulting firms and surveys more than 1,000 senior executives to determine the best management consulting firms based on recent performance and first-hand experience. The list…
Read Now
Leading global life sciences consulting firm Trinity today released a new whitepaper analyzing the oncology clinical trial pipeline to determine the extent to which basket trials are being utilized and, in particular, how many are likely to be registrational studies resulting in tissue-agnostic indications.
Historically, basket trials have been used to explore multiple tumor types in one trial in order to prioritize the ones with the greatest response for further research. However, with Keytruda’s MSI-H and dMMR approval, basket trials…
Read Now
Boston, MA, May 15, 2018 – Trinity, a leading global life sciences consulting firm, today announced it will attend several important industry events across the U.S. this month. Covering topics ranging from innovation and endocrinology research to managed care, Trinity leaders are looking forward to presenting on and learning the latest updates in rare disease and patient advocacy, health care expenditure and the patient journey to continue to help clients make informed decisions in today’s continuously evolving business landscape.
Life…
Read Now
Boston, MA, April 10, 2018 – Trinity, a leading global life sciences consulting firm, today announced it will participate in eyeforpharma’s 16th Annual Meeting, April 10-11, in Philadelphia, PA.
This year’s eyeforpharma meeting is designed to provide life sciences executives with greater insight into the patient journey. Presenters will highlight strategies to leverage advanced analytics and communication channels and unite organizations around the patient to deliver real value.
“Treatments are becoming more targeted and patients are more involved in the…
Read Now
Rare Disease Day falls on Wednesday, February 28th. At Trinity, we work closely with many life sciences companies developing treatments for rare disease patients. Research is crucial to the rare community, and we are committed to help raise awareness around the importance of medical representation for individuals with rare diseases and their families. Keep an eye on our social media channels this week for some rare disease-focused updates and read on to learn what Rare Disease Day means to Trinity…
Read Now
In a recent article for Managed Healthcare Executive, editor Tracey Walker spoke with Trinity’s Jillian Godfrey Scaife about the findings of Trinity’s recent biosimilar whitepaper. In the article, Jillian highlights key takeaways from the findings. You can read the full story including further insights from Jillian here: http://bit.ly/2Br1FsD…
Read Now
Complex Pricing Structures, Legal and Regulatory Barriers,
and Clinical Uncertainty Hinder Progress in Biosimilar Market Access
Key findings from the report, which seeks to reveal opportunities to accelerate biosimilar adoption, include the following:
Biosimilar pricing to date has not offered the sharp discounts payers expect, after accounting for contract discounts and nuances such as the “rebate trap”;
Biologic innovators have taken legal and promotional actions that derail biosimilar commercial success;
Providers are not fully comfortable with biosimilars and are interested…
Read Now
